Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Antirheumatics Pharmaceutical Revenue 1.4 Market Analysis by Type 1.4.1 Global Antirheumatics Pharmaceutical Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Non-Steroidal Anti-Inflammatory Drugs 1.4.3 Steroidal Anti-Inflammatory Drugs 1.4.4 Slow Acting Drug 1.4.5 Immunological Preparation 1.5 Market by Application 1.5.1 Global Antirheumatics Pharmaceutical Market Share by Application: 2020 VS 2026 1.5.2 Pharmaceutical Industry 1.5.3 Hospital and Clinic 1.5.4 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Antirheumatics Pharmaceutical Market Perspective (2015-2026) 2.2 Antirheumatics Pharmaceutical Growth Trends by Regions 2.2.1 Antirheumatics Pharmaceutical Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Antirheumatics Pharmaceutical Historic Market Share by Regions (2015-2020) 2.2.3 Antirheumatics Pharmaceutical Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Antirheumatics Pharmaceutical Market Growth Strategy 2.3.6 Primary Interviews with Key Antirheumatics Pharmaceutical Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Antirheumatics Pharmaceutical Players by Market Size 3.1.1 Global Top Antirheumatics Pharmaceutical Players by Revenue (2015-2020) 3.1.2 Global Antirheumatics Pharmaceutical Revenue Market Share by Players (2015-2020) 3.1.3 Global Antirheumatics Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Antirheumatics Pharmaceutical Market Concentration Ratio 3.2.1 Global Antirheumatics Pharmaceutical Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Antirheumatics Pharmaceutical Revenue in 2019 3.3 Antirheumatics Pharmaceutical Key Players Head office and Area Served 3.4 Key Players Antirheumatics Pharmaceutical Product Solution and Service 3.5 Date of Enter into Antirheumatics Pharmaceutical Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Antirheumatics Pharmaceutical Historic Market Size by Type (2015-2020) 4.2 Global Antirheumatics Pharmaceutical Forecasted Market Size by Type (2021-2026) 5 Antirheumatics Pharmaceutical Breakdown Data by Application (2015-2026) 5.1 Global Antirheumatics Pharmaceutical Market Size by Application (2015-2020) 5.2 Global Antirheumatics Pharmaceutical Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Antirheumatics Pharmaceutical Market Size (2015-2020) 6.2 Antirheumatics Pharmaceutical Key Players in North America (2019-2020) 6.3 North America Antirheumatics Pharmaceutical Market Size by Type (2015-2020) 6.4 North America Antirheumatics Pharmaceutical Market Size by Application (2015-2020) 7 Europe 7.1 Europe Antirheumatics Pharmaceutical Market Size (2015-2020) 7.2 Antirheumatics Pharmaceutical Key Players in Europe (2019-2020) 7.3 Europe Antirheumatics Pharmaceutical Market Size by Type (2015-2020) 7.4 Europe Antirheumatics Pharmaceutical Market Size by Application (2015-2020) 8 China 8.1 China Antirheumatics Pharmaceutical Market Size (2015-2020) 8.2 Antirheumatics Pharmaceutical Key Players in China (2019-2020) 8.3 China Antirheumatics Pharmaceutical Market Size by Type (2015-2020) 8.4 China Antirheumatics Pharmaceutical Market Size by Application (2015-2020) 9 Japan 9.1 Japan Antirheumatics Pharmaceutical Market Size (2015-2020) 9.2 Antirheumatics Pharmaceutical Key Players in Japan (2019-2020) 9.3 Japan Antirheumatics Pharmaceutical Market Size by Type (2015-2020) 9.4 Japan Antirheumatics Pharmaceutical Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Antirheumatics Pharmaceutical Market Size (2015-2020) 10.2 Antirheumatics Pharmaceutical Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Antirheumatics Pharmaceutical Market Size by Type (2015-2020) 10.4 Southeast Asia Antirheumatics Pharmaceutical Market Size by Application (2015-2020) 11 India 11.1 India Antirheumatics Pharmaceutical Market Size (2015-2020) 11.2 Antirheumatics Pharmaceutical Key Players in India (2019-2020) 11.3 India Antirheumatics Pharmaceutical Market Size by Type (2015-2020) 11.4 India Antirheumatics Pharmaceutical Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Antirheumatics Pharmaceutical Market Size (2015-2020) 12.2 Antirheumatics Pharmaceutical Key Players in Central & South America (2019-2020) 12.3 Central & South America Antirheumatics Pharmaceutical Market Size by Type (2015-2020) 12.4 Central & South America Antirheumatics Pharmaceutical Market Size by Application (2015-2020) 13Key Players Profiles 13.1 AbbVie 13.1.1 AbbVie Company Details 13.1.2 AbbVie Business Overview and Its Total Revenue 13.1.3 AbbVie Antirheumatics Pharmaceutical Introduction 13.1.4 AbbVie Revenue in Antirheumatics Pharmaceutical Business (2015-2020)) 13.1.5 AbbVie Recent Development 13.2 Amgen 13.2.1 Amgen Company Details 13.2.2 Amgen Business Overview and Its Total Revenue 13.2.3 Amgen Antirheumatics Pharmaceutical Introduction 13.2.4 Amgen Revenue in Antirheumatics Pharmaceutical Business (2015-2020) 13.2.5 Amgen Recent Development 13.3 Pfizer 13.3.1 Pfizer Company Details 13.3.2 Pfizer Business Overview and Its Total Revenue 13.3.3 Pfizer Antirheumatics Pharmaceutical Introduction 13.3.4 Pfizer Revenue in Antirheumatics Pharmaceutical Business (2015-2020) 13.3.5 Pfizer Recent Development 13.4 Roche Holding AG 13.4.1 Roche Holding AG Company Details 13.4.2 Roche Holding AG Business Overview and Its Total Revenue 13.4.3 Roche Holding AG Antirheumatics Pharmaceutical Introduction 13.4.4 Roche Holding AG Revenue in Antirheumatics Pharmaceutical Business (2015-2020) 13.4.5 Roche Holding AG Recent Development 13.5 Novartis International AG 13.5.1 Novartis International AG Company Details 13.5.2 Novartis International AG Business Overview and Its Total Revenue 13.5.3 Novartis International AG Antirheumatics Pharmaceutical Introduction 13.5.4 Novartis International AG Revenue in Antirheumatics Pharmaceutical Business (2015-2020) 13.5.5 Novartis International AG Recent Development 13.6 Johnson & Johnson 13.6.1 Johnson & Johnson Company Details 13.6.2 Johnson & Johnson Business Overview and Its Total Revenue 13.6.3 Johnson & Johnson Antirheumatics Pharmaceutical Introduction 13.6.4 Johnson & Johnson Revenue in Antirheumatics Pharmaceutical Business (2015-2020) 13.6.5 Johnson & Johnson Recent Development 13.7 Bristol-Myers Squibb 13.7.1 Bristol-Myers Squibb Company Details 13.7.2 Bristol-Myers Squibb Business Overview and Its Total Revenue 13.7.3 Bristol-Myers Squibb Antirheumatics Pharmaceutical Introduction 13.7.4 Bristol-Myers Squibb Revenue in Antirheumatics Pharmaceutical Business (2015-2020) 13.7.5 Bristol-Myers Squibb Recent Development 13.8 Merck 13.8.1 Merck Company Details 13.8.2 Merck Business Overview and Its Total Revenue 13.8.3 Merck Antirheumatics Pharmaceutical Introduction 13.8.4 Merck Revenue in Antirheumatics Pharmaceutical Business (2015-2020) 13.8.5 Merck Recent Development 13.9 UCB S.A. 13.9.1 UCB S.A. Company Details 13.9.2 UCB S.A. Business Overview and Its Total Revenue 13.9.3 UCB S.A. Antirheumatics Pharmaceutical Introduction 13.9.4 UCB S.A. Revenue in Antirheumatics Pharmaceutical Business (2015-2020) 13.9.5 UCB S.A. Recent Development 13.10 Eli Lilly and Company 13.10.1 Eli Lilly and Company Company Details 13.10.2 Eli Lilly and Company Business Overview and Its Total Revenue 13.10.3 Eli Lilly and Company Antirheumatics Pharmaceutical Introduction 13.10.4 Eli Lilly and Company Revenue in Antirheumatics Pharmaceutical Business (2015-2020) 13.10.5 Eli Lilly and Company Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Antirheumatics Pharmaceutical Key Market Segments Table 2. Key Players Covered: Ranking by Antirheumatics Pharmaceutical Revenue Table 3. Ranking of Global Top Antirheumatics Pharmaceutical Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Antirheumatics Pharmaceutical Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Non-Steroidal Anti-Inflammatory Drugs Table 6. Key Players of Steroidal Anti-Inflammatory Drugs Table 7. Key Players of Slow Acting Drug Table 8. Key Players of Immunological Preparation Table 9. Global Antirheumatics Pharmaceutical Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 10. Global Antirheumatics Pharmaceutical Market Size by Regions (US$ Million): 2020 VS 2026 Table 11. Global Antirheumatics Pharmaceutical Market Size by Regions (2015-2020) (US$ Million) Table 12. Global Antirheumatics Pharmaceutical Market Share by Regions (2015-2020) Table 13. Global Antirheumatics Pharmaceutical Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 14. Global Antirheumatics Pharmaceutical Market Share by Regions (2021-2026) Table 15. Market Top Trends Table 16. Key Drivers: Impact Analysis Table 17. Key Challenges Table 18. Antirheumatics Pharmaceutical Market Growth Strategy Table 19. Main Points Interviewed from Key Antirheumatics Pharmaceutical Players Table 20. Global Antirheumatics Pharmaceutical Revenue by Players (2015-2020) (Million US$) Table 21. Global Antirheumatics Pharmaceutical Market Share by Players (2015-2020) Table 22. Global Top Antirheumatics Pharmaceutical Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antirheumatics Pharmaceutical as of 2019) Table 23. Global Antirheumatics Pharmaceutical by Players Market Concentration Ratio (CR5 and HHI) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Antirheumatics Pharmaceutical Product Solution and Service Table 26. Date of Enter into Antirheumatics Pharmaceutical Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Antirheumatics Pharmaceutical Market Size by Type (2015-2020) (Million US$) Table 29. Global Antirheumatics Pharmaceutical Market Size Share by Type (2015-2020) Table 30. Global Antirheumatics Pharmaceutical Revenue Market Share by Type (2021-2026) Table 31. Global Antirheumatics Pharmaceutical Market Size Share by Application (2015-2020) Table 32. Global Antirheumatics Pharmaceutical Market Size by Application (2015-2020) (Million US$) Table 33. Global Antirheumatics Pharmaceutical Market Size Share by Application (2021-2026) Table 34. North America Key Players Antirheumatics Pharmaceutical Revenue (2019-2020) (Million US$) Table 35. North America Key Players Antirheumatics Pharmaceutical Market Share (2019-2020) Table 36. North America Antirheumatics Pharmaceutical Market Size by Type (2015-2020) (Million US$) Table 37. North America Antirheumatics Pharmaceutical Market Share by Type (2015-2020) Table 38. North America Antirheumatics Pharmaceutical Market Size by Application (2015-2020) (Million US$) Table 39. North America Antirheumatics Pharmaceutical Market Share by Application (2015-2020) Table 40. Europe Key Players Antirheumatics Pharmaceutical Revenue (2019-2020) (Million US$) Table 41. Europe Key Players Antirheumatics Pharmaceutical Market Share (2019-2020) Table 42. Europe Antirheumatics Pharmaceutical Market Size by Type (2015-2020) (Million US$) Table 43. Europe Antirheumatics Pharmaceutical Market Share by Type (2015-2020) Table 44. Europe Antirheumatics Pharmaceutical Market Size by Application (2015-2020) (Million US$) Table 45. Europe Antirheumatics Pharmaceutical Market Share by Application (2015-2020) Table 46. China Key Players Antirheumatics Pharmaceutical Revenue (2019-2020) (Million US$) Table 47. China Key Players Antirheumatics Pharmaceutical Market Share (2019-2020) Table 48. China Antirheumatics Pharmaceutical Market Size by Type (2015-2020) (Million US$) Table 49. China Antirheumatics Pharmaceutical Market Share by Type (2015-2020) Table 50. China Antirheumatics Pharmaceutical Market Size by Application (2015-2020) (Million US$) Table 51. China Antirheumatics Pharmaceutical Market Share by Application (2015-2020) Table 52. Japan Key Players Antirheumatics Pharmaceutical Revenue (2019-2020) (Million US$) Table 53. Japan Key Players Antirheumatics Pharmaceutical Market Share (2019-2020) Table 54. Japan Antirheumatics Pharmaceutical Market Size by Type (2015-2020) (Million US$) Table 55. Japan Antirheumatics Pharmaceutical Market Share by Type (2015-2020) Table 56. Japan Antirheumatics Pharmaceutical Market Size by Application (2015-2020) (Million US$) Table 57. Japan Antirheumatics Pharmaceutical Market Share by Application (2015-2020) Table 58. Southeast Asia Key Players Antirheumatics Pharmaceutical Revenue (2019-2020) (Million US$) Table 59. Southeast Asia Key Players Antirheumatics Pharmaceutical Market Share (2019-2020) Table 60. Southeast Asia Antirheumatics Pharmaceutical Market Size by Type (2015-2020) (Million US$) Table 61. Southeast Asia Antirheumatics Pharmaceutical Market Share by Type (2015-2020) Table 62. Southeast Asia Antirheumatics Pharmaceutical Market Size by Application (2015-2020) (Million US$) Table 63. Southeast Asia Antirheumatics Pharmaceutical Market Share by Application (2015-2020) Table 64. India Key Players Antirheumatics Pharmaceutical Revenue (2019-2020) (Million US$) Table 65. India Key Players Antirheumatics Pharmaceutical Market Share (2019-2020) Table 66. India Antirheumatics Pharmaceutical Market Size by Type (2015-2020) (Million US$) Table 67. India Antirheumatics Pharmaceutical Market Share by Type (2015-2020) Table 68. India Antirheumatics Pharmaceutical Market Size by Application (2015-2020) (Million US$) Table 69. India Antirheumatics Pharmaceutical Market Share by Application (2015-2020) Table 70. Central & South America Key Players Antirheumatics Pharmaceutical Revenue (2019-2020) (Million US$) Table 71. Central & South America Key Players Antirheumatics Pharmaceutical Market Share (2019-2020) Table 72. Central & South America Antirheumatics Pharmaceutical Market Size by Type (2015-2020) (Million US$) Table 73. Central & South America Antirheumatics Pharmaceutical Market Share by Type (2015-2020) Table 74. Central & South America Antirheumatics Pharmaceutical Market Size by Application (2015-2020) (Million US$) Table 75. Central & South America Antirheumatics Pharmaceutical Market Share by Application (2015-2020) Table 76. AbbVie Company Details Table 77. AbbVie Business Overview Table 78. AbbVie Product Table 79. AbbVie Revenue in Antirheumatics Pharmaceutical Business (2015-2020) (Million US$) Table 80. AbbVie Recent Development Table 81. Amgen Company Details Table 82. Amgen Business Overview Table 83. Amgen Product Table 84. Amgen Revenue in Antirheumatics Pharmaceutical Business (2015-2020) (Million US$) Table 85. Amgen Recent Development Table 86. Pfizer Company Details Table 87. Pfizer Business Overview Table 88. Pfizer Product Table 89. Pfizer Revenue in Antirheumatics Pharmaceutical Business (2015-2020) (Million US$) Table 90. Pfizer Recent Development Table 91. Roche Holding AG Company Details Table 92. Roche Holding AG Business Overview Table 93. Roche Holding AG Product Table 94. Roche Holding AG Revenue in Antirheumatics Pharmaceutical Business (2015-2020) (Million US$) Table 95. Roche Holding AG Recent Development Table 96. Novartis International AG Company Details Table 97. Novartis International AG Business Overview Table 98. Novartis International AG Product Table 99. Novartis International AG Revenue in Antirheumatics Pharmaceutical Business (2015-2020) (Million US$) Table 100. Novartis International AG Recent Development Table 101. Johnson & Johnson Company Details Table 102. Johnson & Johnson Business Overview Table 103. Johnson & Johnson Product Table 104. Johnson & Johnson Revenue in Antirheumatics Pharmaceutical Business (2015-2020) (Million US$) Table 105. Johnson & Johnson Recent Development Table 106. Bristol-Myers Squibb Company Details Table 107. Bristol-Myers Squibb Business Overview Table 108. Bristol-Myers Squibb Product Table 109. Bristol-Myers Squibb Revenue in Antirheumatics Pharmaceutical Business (2015-2020) (Million US$) Table 110. Bristol-Myers Squibb Recent Development Table 111. Merck Business Overview Table 112. Merck Product Table 113. Merck Company Details Table 114. Merck Revenue in Antirheumatics Pharmaceutical Business (2015-2020) (Million US$) Table 115. Merck Recent Development Table 116. UCB S.A. Company Details Table 117. UCB S.A. Business Overview Table 118. UCB S.A. Product Table 119. UCB S.A. Revenue in Antirheumatics Pharmaceutical Business (2015-2020) (Million US$) Table 120. UCB S.A. Recent Development Table 121. Eli Lilly and Company Company Details Table 122. Eli Lilly and Company Business Overview Table 123. Eli Lilly and Company Product Table 124. Eli Lilly and Company Revenue in Antirheumatics Pharmaceutical Business (2015-2020) (Million US$) Table 125. Eli Lilly and Company Recent Development Table 126. Research Programs/Design for This Report Table 127. Key Data Information from Secondary Sources Table 128. Key Data Information from Primary Sources List of Figures Figure 1. Global Antirheumatics Pharmaceutical Market Share by Type: 2020 VS 2026 Figure 2. Non-Steroidal Anti-Inflammatory Drugs Features Figure 3. Steroidal Anti-Inflammatory Drugs Features Figure 4. Slow Acting Drug Features Figure 5. Immunological Preparation Features Figure 6. Global Antirheumatics Pharmaceutical Market Share by Application: 2020 VS 2026 Figure 7. Pharmaceutical Industry Case Studies Figure 8. Hospital and Clinic Case Studies Figure 9. Other Case Studies Figure 10. Antirheumatics Pharmaceutical Report Years Considered Figure 11. Global Antirheumatics Pharmaceutical Market Size YoY Growth 2015-2026 (US$ Million) Figure 12. Global Antirheumatics Pharmaceutical Market Share by Regions: 2020 VS 2026 Figure 13. Global Antirheumatics Pharmaceutical Market Share by Regions (2021-2026) Figure 14. Porter's Five Forces Analysis Figure 15. Global Antirheumatics Pharmaceutical Market Share by Players in 2019 Figure 16. Global Top Antirheumatics Pharmaceutical Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antirheumatics Pharmaceutical as of 2019 Figure 17. The Top 10 and 5 Players Market Share by Antirheumatics Pharmaceutical Revenue in 2019 Figure 18. North America Antirheumatics Pharmaceutical Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Europe Antirheumatics Pharmaceutical Market Size YoY Growth (2015-2020) (Million US$) Figure 20. China Antirheumatics Pharmaceutical Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Japan Antirheumatics Pharmaceutical Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Southeast Asia Antirheumatics Pharmaceutical Market Size YoY Growth (2015-2020) (Million US$) Figure 23. India Antirheumatics Pharmaceutical Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Central & South America Antirheumatics Pharmaceutical Market Size YoY Growth (2015-2020) (Million US$) Figure 25. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. AbbVie Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2015-2020) Figure 27. Amgen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Amgen Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2015-2020) Figure 29. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Pfizer Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2015-2020) Figure 31. Roche Holding AG Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Roche Holding AG Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2015-2020) Figure 33. Novartis International AG Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Novartis International AG Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2015-2020) Figure 35. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Johnson & Johnson Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2015-2020) Figure 37. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Bristol-Myers Squibb Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2015-2020) Figure 39. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Merck Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2015-2020) Figure 41. UCB S.A. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. UCB S.A. Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2015-2020) Figure 43. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. Eli Lilly and Company Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2015-2020) Figure 45. Bottom-up and Top-down Approaches for This Report Figure 46. Data Triangulation Figure 47. Key Executives Interviewed

AbbVie Amgen Pfizer Roche Holding AG Novartis International AG Johnson & Johnson Bristol-Myers Squibb Merck UCB S.A. Eli Lilly and Company